Cerebral edema is a potentially life-threatening illness, but knowledge of its underlying mechanisms is limited. Here we report that hypobaric hypoxia induces rat cerebral edema and neuronal apoptosis and increases the expression of corticotrophin releasing factor (CRF), CRF receptor type 1 (CRFR1), aquaporin-4 (AQP4), and endothelin-1 (ET-1) in the cortex. These effects, except for the increased expression of CRF itself, could all be blocked by pretreatment with an antagonist of the CRF receptor CRFR1. We also show that, in cultured primary astrocytes: (i) both CRFR1 and AQP4 are expressed; (ii) exogenous CRF, acting through CRFR1, triggers signaling of cAMP/PKA, intracellular Ca
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water permeability | high altitude | acute mountain sickness A pproximately 140 million people around the world live at altitudes of >2,500 m, including >8 million who live on the Qinghai-Tibet plateau of China at an average elevation of >4,000 m. Living at these altitudes requires physiological adaptations to compensate for the lower partial pressure of oxygen (1) . In travelers who ascend to altitudes too high or too quickly (2) (3) (4) or in people with fatigue and infection or psychological stress (3, 4) , hypoxia can induce acute mountain sickness (AMS) that can develop into high-altitude cerebral edema (HACE), a serious and often fatal condition (2-6). Today's ability to travel rapidly to high altitudes means that, every year, millions of people are exposed to the risk of AMS and HACE (7) .
In human volunteers exposed for 32 h to hypobaric hypoxia (corresponding to 4,572 m altitude), brain volume increases by 2.77% (8) , whereas normobaric hypoxia (12% O 2 , corresponding to a simulated altitude of 4,500 m) for 16 h produces 50% AMS, headache, a mild increase in brain volume, and cytotoxic cerebral edema (9) . A recent study reported that seven of nine male students exposed to isobaric hypoxia (inhaled room air enriched with N 2 for 6 h to obtain arterial saturation values of 75-80%) developed AMS; the mean apparent diffusion coefficient (ADC) increased by 2.12% in these subjects, indicating mild extracellular (vasogenic) cerebral edema. The ADC changes were negatively correlated with AMS scores, suggesting that severe AMS is associated with intracellular (cytotoxic) cerebral edema in addition to vasogenic edema (10) .
In parallel with the increasing brain water content, hypoxia acutely activates the hypothalamic-pituitary-adrenal axis in rats (11-13), increasing corticotropin-releasing factor (CRF) and endothelin-1 (ET-1) expression in the paraventricular nucleus of the hypothalamus (14) . We previously showed that these effects are mediated by CRF receptor 1 (CRFR1) (12, 14) . These observations led us to speculate that other CRF systems in the brain (15, 16) might also be involved in the response to hypoxia.
Aquaporin-4 (AQP4), a water channel protein, is expressed in astrocytes, especially in the foot processes (17) , and is a primary influx route for water during brain edema in pathologies such as brain injury, stroke, and brain tumors. Because both CRF and its receptor are widely distributed in the central and peripheral nervous systems (18) (19) (20) (21) , including in astrocytes, microglia, and neurons of the cortex (22) , we hypothesized that cortical astrocytes that express both CRFR1 and AQP4 might be involved in hypoxia-induced brain edema.
In this study, we addressed the hypothesis that, during highaltitude hypoxia, CRF mediates cerebral edema through CRFR1 signaling and AQP4 activation in cortical astrocytes.
Results
Hypoxia-Induced Cerebral Edema and CRF, CRFR1, and AQP4 Activation.
To determine whether high-altitude hypoxia induces HACE, rats were exposed to simulated high-altitude hypoxia, simulating an Significance High-altitude cerebral edema, a serious and often fatal condition, results from lowered oxygen supply. This study explores the mechanisms by which hypoxia induces cerebral edema. We show that hypoxia induced cerebral edema and neuronal apoptosis associated with increased expression of the neuropeptide corticotrophin releasing factor (CRF) and its type 1 receptor (CRFR1), the water channel aquaporin-4 (AQP4), and endothelin-1; these effects could be blocked by the CRFR1 antagonist. In cultured astrocytes, CRF, acting through CRFR1, triggers intracellular signaling and contributes to phosphorylation and expression of AQP4 to enhance water influx into cells. These data provide an understanding of the development of cerebral edema by high-altitude hypoxia and suggest that CRFR1 might be a target molecule for prevention of this disorder.
altitude of 7,000 m (equivalent to 7.8% O 2 at sea level) for 8 h to acutely induce hypoxic brain edema. To study the role of CRFR1, the CRFR1-specific antagonist CP154,526 [N-butyl-N-ethyl-4,9-dimethyl-7-(2,4,6-trimethylphenyl)-3,5,7-triazabicyclo[4.3.0]nona-2,4,8,10-tetraen-2-amine] (15 or 30 mg per kg of body weight) was injected s.c. 30 min before the rats were subjected to hypoxia. The hypoxia resulted in brain edema, detected by magnetic resonance imaging (MRI) as a significant increase in ADC of the brain ( Fig.  1 A and B) and by an increase in whole-brain water content (Fig.  1C) . These effects were blocked by CP154,526 at 30 mg/kg, but not at 15 mg/kg.
We then measured the effects of hypoxia on the expression of CRF, CRF mRNA, CRFR1 mRNA, AQP4, and AQP4 mRNA in the frontal cortex. The levels of all were markedly increased by hypoxia (Fig. 1 D-F) , and, as expected, the plasma concentration of corticosterone was also increased (Fig. 1G) . Pretreatment with CP154,526 (30 mg/kg) blocked the increases in CRFR1 mRNA, AQP4, and AQP4 mRNA expression and the increase in corticosterone secretion, without affecting the basal level (Figs. 1G and 2B). We omitted glucocorticoid replacement to probe the mechanisms underlying HACE, because cortisol levels are not correlated with the severity of AMS in humans (23) . Pretreatment with CP154,526 had no significant effect on CRF content or CRF mRNA expression in the cortex (Fig. 1E) . Thus, we hypothesized that, under hypoxia, the local increases in the expression and release of CRF play a major role in the elevated expression of AQP4 in the cortex, acting via CRFR1 receptors.
Hypoxia-Induced Apoptosis and Apoptotic Gene Expression and ET-1
Activation. Accompanying brain edema and the increased expression of CRF and CRF mRNA, we found significantly increased ET-1 content in the cortex and increased corticosterone in plasma after hypoxia. This increase was also blocked by pretreatment with 30 mg/kg CP154,526, by pretreatment with pyrrolidine dithiocarbamate (PDTC; 150 mg/kg), an inhibitor of nuclear factor kappa B (NF-κB), and by pretreatment with a combination of both ( Fig. 2 A and B) .
We went on to test whether this effect also reflected a local, direct effect of CRF on cortical astrocytes. In cultured astrocytes, 30-min exposure to CRF induced an increased expression of ET-1 mRNA, and the increase of ET-1 mRNA was blocked in the presence of CP154,526. After 8-h exposure to CRF, there was significantly increased ET-1 protein expression, and again this increase of ET-1 protein was blocked by CP154,526 (100 nM; P = 0.08; Fig. 2 C and D) .
Hypoxia produced pyramidal cell swelling, enlargement of the intercellular space, and perivascular vacuoles as shown in H&E-stained sections. Neuronal apoptosis was evident from increased TUNEL labeling (Fig. 2 E and F) , and increased mRNA expression of the apoptotic genes BCL2-associated X (Bax) and Bcl-2-interacting mediator of cell death (Bim) was demonstrated by real-time PCR (Fig. 2G) . All of these effects were blocked by CP154,526, indicating that CRFR1 not only mediates cerebral edema, but also activates apoptotic genes and neuronal apoptosis.
CRFR1 Signaling-Involved AQP4 Phosphorylation and Expression. Using laser-scanning confocal microscopy and triple-labeling immunofluorescence, we identified both CRFR1 and AQP4 expression in the frontal cortex and in cultured purified primary astrocytes, as well as in cultured nonpurified mixed astrocytes (Fig. 3A) . As shown by PCR, cortical neurons expressed CRFR1, but not AQP4, whereas astrocytes expressed both (Fig. S1A ), suggesting that an interaction between CRFR1 and AQP4 involves cerebral astrocytes.
To clarify how CRFR1 signaling results in changed permeability and enhanced water influx into astrocytes, we investigated the activation of intracellular signaling pathways in cultured astrocytes in response to CRF challenge under normoxic (21% O 2 , 74% N, 5% CO 2 ) and hypoxic (1% O 2 , 94% N, 5% CO 2 ) conditions. Phosphorylation sites on the C-terminal of AQP4 for protein kinase A (PKA), PKC, and calcium/calmodulin-dependent (30 mg/kg) (n = 6 or 7 per group). *P < 0.05 (vs. control); # P < 0.05 (vs. hypoxia). (B) Representative MRI images of rat brain: control, hypoxia, and pretreatment with CP154,526 + hypoxia (hypoxia+ CP154,526). (Scale bar: 1 mm.) (C) Elevation of brain water content after hypoxia was blocked by CP154,526 (n = 6 or 7). **P < 0.01 (vs. control); ## P < 0.01 (vs. hypoxia). (D) Hypoxia increased the expression of AQP4 and AQP4 mRNA in the cortex, and the increase of AQP4 protein and AQP4 mRNA was blocked by CP154,526 (n = 6 or 7). **P < 0.01; ***P < 0.001 (vs. control); # P < 0.05; ## P < 0.01 (hypoxia vs. antagonist + hypoxia). (E) Hypoxia-induced increases in CRF content and CRF mRNA expression in cortex were not abolished by CP154,526 (n = 6 or 7). ***P < 0.001 (vs. control). (F) CRFR1 mRNA expression in the cortex was increased by hypoxia, and this increase was abolished by CP154,526 (n = 6 or 7). ***P < 0.001 (vs. control); ## P < 0.01 (vs. hypoxia). (G) Hypoxia increased the plasma concentration of corticosterone and this effect was abolished by CP154,526 (n = 6 or 7). ***P < 0.001 (vs. control); ### P < 0.001 (vs. hypoxia).
protein kinase II (CaMKII) binding are all known to contribute to the action of AQP4 in inducing brain edema (24) .
In cultured astrocytes, exposure to 10 nM CRF for 30 min increased AQP4 mRNA expression, and this increase could be blocked by CP154,526 (Fig. 3B ). After 8-h exposure, the expression of AQP4 protein was also significantly increased, and the increase of AQP4 protein was completely blocked by pretreatment with CP154,526 in both normoxic or hypoxic conditions (Fig. 3C) .
Exposure to CRF (1 or 10 nM) for 30 min activated Gs expression ( Fig. 3D ) and increased cAMP concentrations, and the cAMP increase was blocked by preincubation with CP154,526 (Fig. 3E) . Expression of the PKC-e isoform was enhanced after exposure to CRF for 2 or 8 h (Fig. 3F ), but that of PKC-βII or PKC-γ was not changed. Finally, CRF triggered the phosphorylation of AQP4 protein at the PKA and PKC binding sites, and the AQP4 phosphorylation, too, could be blocked by CP154,526 (Fig. 3G) .
Exposure of cultured primary astrocytes to CRF resulted in intracellular Ca 2+ ([Ca   2+ ] i ) oscillations observed with confocal microscopy. The oscillations reached a peak within several seconds, thereafter gradually dropping to basal level by 50 s (Fig. S1B) . The CRF-triggered oscillations could be observed in Ca 2+ -free medium (Fig. 3H) , as well as in medium with 1.25 mmol/L Ca 2+ (Fig. S1C ), indicating that they arose from mobilization of intracellular stores. The oscillations were abolished by preincubation with CP154,526 (100 nM) 30 min before CRF loading (Fig. 3I ). The [Ca 2+ ] i oscillations depended on CRF concentration and were reduced by 100 nM CRF (Fig. S1D ).
HIF-1α Is Not Involved in Hypoxia-Induced Astrocyte Swelling. We then tested whether cellular hypoxia activates the inducible nitric oxide synthase (iNOS)-NO-PKG signaling pathway (25) through hypoxia inducible factor 1α (HIF-1α) to regulate AQP4 in cortical astrocytes. Hypoxia (1% O 2 , 30 min) increased HIF-1α mRNA expression in purified astrocytes ( Fig. S2A ) but had no effect on iNOS mRNA expression or on PKGI (∼85 kDa), PKGII (∼75 kDa) (Fig.  S2C ), or phosphorylated AQP4 (Fig. S2D ) in these cells, and a PKG inhibitor had no significant effect (Fig. S2C ). By contrast, in nonpurified astrocytes, hypoxia significantly increased iNOS mRNA expression (Fig. S2B) ; Thus, hypoxia-activated HIF-1α did not directly contribute to the activation of iNOS, PKG, and AQP4 in cultured purified astrocytes, but it contributed to the up-regulation of iNOS in mixed cultures, potentially via the activation of microglia (26) . Acute hypoxia induces hypocapnia (27, 28) , which causes brain injury (29) ; NO production in cerebral endothelial cells is decreased, but unchanged, in astrocytes during hypocapnia independent of pH (30) , suggesting that endothelial cells may also play a role in modulating NOS activity.
CRF-Induced Cell Swelling in Transgenic CHO Cells Transfected with CRFR1
+ and AQP4
To confirm that CRFR1 signaling activates AQP4 and thereby induces cell swelling, we established a transgenic CHO cell model. CHO cells were transfected + cells. We identified these cells by quantitative real-time PCR and assessed their swelling in response to switching the culture medium from 300 mOsm PBS to hypoosmotic (200 mOsm) PBS, with or without CRF (10 nM) and CP154,526.
The CHO-rCRFR1 + /rAQP4 + cells were significantly more swollen than the CHO-rCRFR1
+ cells when challenged by CRF (10 nM), and this difference was completely abolished by CP154,526 (Fig. 4A) . Thus, the transfected rCRFR1 plays a stimulatory role in activating the transfected rAQP4, leading to enhanced water permeability of the CHO-rCRFR1 + /rAQP4 + cells. Exposure to CRF (10 nM) immediately increased the water permeability of cultured primary cortical astrocytes, and the water permeability was fully abolished by preincubation with CP154,526 (100 nM) (Fig. 4B) or 5-chloro-4-[N-(cyclopropyl)methyl-N-propylamino]-2-methyl-6-(2,4,6-trichlorophenyl) aminopyridine (NBI; 100 nM; another CRFR1 antagonist) for 30 min (Fig. S3B ).
CRFR1-Activated ET-1 Expression in Astrocytes. In cultured cortical astrocytes, CRF stimulated an increase in ET-1 mRNA expression and AQP4 mRNA expression by 30 min and up-regulated ET-1 protein by 8 h; all of these effects were blocked by NBI (Fig. S3 B and C) . Thus, CRFR1 mediates the observed increases in ET-1 and ET-mRNA expression as well as the increase in AQP4 mRNA expression.
Discussion
Overview. Here, we showed that exposure to 7.8% O 2 (equivalent to 7,000 m altitude) for 8 h induced cerebral edema and neuronal apoptosis, apoptotic gene expression in rats that depend upon CRFR1 activation, because it was blocked by a CRFR1 antagonist. This hypoxia-induced edema is consistent with clinical reports that high-altitude hypoxia may induce human brain edema. We suggest that there may be a "window of opportunity" for therapy or prevention of hypoxia-induced cerebral edema and apoptosis. (31) . Ischemia induces upregulation of expression of ET-1/3 and its receptors-A/B in the rat cortex (33) , and activation of ET-1 by ischemia induces brain edema via AQP4 in rat astrocytic end-feet (34) . In the present study, hypobaric hypoxia-activated cortical ET-1 is also involved in cerebral edema and apoptosis through activation of both CRFR1 and NF-κB, suggesting that antagonists for CRFR1 and ET-1R might be appropriate for treating hypoxia-induced disorders.
CRFR1 Involved in
We found that hypoxia up-regulates ET-1 and induces apoptosis in the cortex and that CRF stimulates ET-1 expression in cultured cerebral astrocytes. All of these effects could be blocked by treatment with a CRFR1 antagonist, suggesting that CRF and its receptor CRFR1 have a key role in hypoxic cerebral edema and apoptosis. In humans, ET-1 levels >5.5 fmol/mL in serum are linked to severe brain edema in acute stroke patients (35) . ET-1 A plays a protective role during brain edema (36) , but ET-1 B receptors also regulate astrocytic function (31); in an experimental rat model of stroke, an ET-1 B antagonist could reduce brain edema, serum ET-1, and astrocyte swelling (37) . Recently, ET-1 has been shown to promote NO production and astrocyte migration by activation of ET-1 B and NF-κB, inducing iNOS (38) . Importantly, hypoxia elicited a parallel increase of both ET-1 and AQP4 expression in rat cortex, which depended on the activation of both CRFR1 and the NF-κB pathway.
CRFR1 Involved in Brain Edema and AQP4 Expression. AQP4, the most abundant water channel in the brain, is expressed in astrocytes, particularly in the end feet, and promotes water clearance from swelling cells (39) . Increased expression of AQP4 in the brain is associated with cerebral edema and related neurological disorders (40) (41) (42) (43) , and AQP4-deficient mice survive better than wild-type mice in a model of brain edema (41) .
AQP4 activity is regulated in the short-term by phosphorylation, trafficking, binding with inhibitor, and protein-protein interactions, and in the long-term by changes in mRNA expression, protein synthesis, and degradation (24) . We found that 8-h hypoxia (7.8% O 2 ) up-regulated AQP4 protein and AQP4 mRNA expression in rat cortex, along with increasing expression of CRF, CRF mRNA, and CRFR1 mRNA. By contrast, hypoxia (1% O 2 ) or 10 nM CRF challenge for 30 min did not up-regulate AQP4 expression in cultured primary astrocytes, but both triggered AQP4 phosphorylation, leading to enhancement of permeability and astrocyte swelling. Thus, in the cerebral cortex, locally released CRF acts via CRFR1 expressed on astrocytes to activate AQP4, which then contributes to cerebral edema.
Hypobaric hypoxia-induced brain edema, including CRFR1-mediated cytotoxic astrocyte edema and vasogenic edema, suggested an integrative working model for hypoxia-induced cerebral edema, because CRFR1 and AQP4 are expressed in astrocytes and cerebral microvessel endothelial cells (Fig. 4C) . A review by Verkman indicates that both cytotoxic and vasogenic brain edema can occur independently or together (44).
CRFR1 Signaling Up-Regulated AQP4. In cultured primary astrocytes, CRF challenge elicited up-regulation of Gs, cAMP/PKA, and PKCe, and triggered [Ca 2+ ] i oscillations, which could be abolished by a CRFR1 antagonist (Fig. 3 D-I ). These effects resulted in the activation of phosphorylated AQP4, as confirmed by coimmunoprecipitation (co-IP), resulting in astrocyte swelling. Activation of CRFR1 also triggered [Ca 2+ ] i oscillations in cultured astrocytes (Fig. 3 H and I) , which may contribute to phosphorylation of AQP4 via PKG, because PKG produces phosphorylated AQP4 (pAQP4) when NO is provided (45) .
It has been reported that AQP4 induces Ca 2+ spike signaling through activation of P2 purinergic receptors in a model of cortical astrocytic edema induced by hypoosmotic stress (46) . However, in cultured primary astrocytes challenged by either CRF or hypoxia, we found no activation of PKGI, PKGII, iNOS, or pAQP4, although HIF-1α was up-regulated (Fig. S2A) . iNOS expression was up-regulated in mixed cultures that contained both astrocytes and microglia (Fig. S2B) . Because CRF can stimulate NO production in cultured rat microglia (26) , PKG may contribute to astrocyte swelling via AQP4 in the presence of CRF-evoked NO release from microglia.
CRF binding to CRFR1 can induce PKC signaling, but at least 12 isoforms of PKC have been described (47, 48) . We found that PKC-e, but not PKC-βII or PKC-γ, is up-regulated in cultured primary astrocytes after CRF challenge (Fig. 3F) ; notably, this PKC-e up-regulation occurred at 2 and 8 h after the onset of CRF stimulation but not after 30 min. By contrast, phosphorylated PKC-bound AQP4 was detectable after 30-min exposure to CRF, and this pAQP4 level was partly reduced by the CRFR1 antagonist (Fig. 3G) . Thus, we suggest that, in the early stage of Model illustrating how hypoxia induces cerebral edema: Hypoxia stimulates CRF release that activates CRFR1 to initiate a signaling cascade that activates AQP4 and causes cell swelling.
hypoxia, AQP4 is phosphorylated by cAMP/PKA, producing acute astrocyte swelling, but subsequently is phosphorylated by PKC-e to reverse water influx. This pAQP4 by PKC-e is consistent with studies showing that activation of PKC can protect cortical neurons and astrocytes from ischemia-like injury, hypoxia, and glucose deprivation (49) .
Conclusions
Our results demonstrate that hypoxia induces rat brain edema and apoptosis (Fig. 4C) . These effects involve activation of CRF and CRFR1 mRNA, CRFR1, which signals through PKA, PKC-e, and [Ca 2+ ] i oscillations in cerebral astrocytes. Phosphorylation of AQP4 by PKA contributes to astrocytic edema at the early stage and phosphorylation by PKC-e to achieve restoration at the later stage. The activated [Ca 2+ ] i does not directly induce edema through PKG in astrocytes, but may do so in the intact brain in the presence of microglia. Hypoxia-activated CRFR1 and ET-1, modulated by CRFR1 and NF-κB, contribute to the activation of apoptosis and apoptotic genes.
Materials and Methods
Adult male Sprague-Dawley rats (300 ± 20 g) in healthy, clean-grade condition (certification no. SCXK2008-0033) were purchased from the Experimental Animal Center of Zhejiang Province (China) and maintained under a 12/12-h light/dark cycle (lights on 06:00-18:00 h) at room temperature (20 ± 2°C), with free access to food and water. Rats were housed in groups of six and adapted to these conditions for 1 wk before experimental manipulation. All animal procedures were performed according to National Institutes of Health guidelines under protocols approved by the Institutional Animal Care and Use Committee of Zhejiang University. The methods used in this study (animal breeding, MRI, confocal imaging, measurement of [Ca 2+ ]i and signal imaging, cell culture, plasmid construction, transient transfection, quantitative real-time RT-PCR, Western blotting, and osmotic water permeability measurements) are described in SI Materials and Methods.
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SI Materials and Methods
Rat. Adult male Sprague-Dawley rats (300 ± 20 g) in healthy, clean-grade condition (certification no. SCXK2008-0033) were purchased from the Experimental Animal Center of Zhejiang Province (China) and maintained under a 12/12-h light/dark cycle (lights on 06:00-18:00 h), at room temperature (20 ± 2°C), with free access to food and water. Rats were housed in groups of six and adapted to these conditions for 1 wk before experimental manipulation. All animal procedures were performed according to National Institutes of Health guidelines under protocols approved by the Institutional Animal Care and Use Committee of Zhejiang University. Magnetic Resonance Imaging. Rats were anesthetized with pentobarbital sodium (30 mg/kg i.p.) before MRI, fixed in a body restrainer, and placed in an MRI spectrometer (GE Medical System; 3T). T2-multiecho images were acquired with a spin-echo sequence with the following parameters: 10 contiguous coronal slices at 2-mm thickness, field of view 24 × 24 mm, matrix 128 × 128, repetition time (TR) = 3,950 ms, echo time (TE) = 102 ms. To map the apparent diffusion coefficient (ADC) of water, diffusion-weighted images were acquired with a spin-echo sequence. Ten contiguous coronal slices were acquired (2-mm thick, field of view 24 × 24 mm, matrix 128 × 128, TR = 6,300 ms, TE = 78.4 ms). ADC maps were automatically calculated according to the following equation: ADC = ln(S 0 /S 1 )/(b 1 − b 0 ) (mm 2 /s). After hypoxic exposure, rats were immediately placed into a MRI scanner (GE) for ADC measurement and imaging. After MRI, rats were rapidly decapitated and the brain was immediately removed, frozen in liquid nitrogen, and stored at −80°C.
Western Blot. Aquaporin-4 (AQP4), inducible nitric oxide synthase (iNOS), PKC, and PKG protein expression was determined by Western blot. Briefly, protein samples from cortex were separated by 10% (wt/vol) SDS-polyacrylamide gel elctrophoresis and transferred to PVDF membranes. The membranes were reacted with a rabbit polyclonal antibody against AQP4 (Chemicon; 1:3,000), iNOS (Chemicon; 1:3,000), and PKG (Chemicon; 1:3,000) at 4°C overnight. After washing, the membranes were sequentially reacted with a horseradish peroxidase-conjugated goat anti-rabbit antibody (Zhongshan; 1:3,000) at room temperature for 1 h. After repeat washes, the membranes were reacted with ECL reagents and exposed to X-ray film to show the bands; AQP4, iNOS, PKC, and PKG were normalized to protein-loading controls (β-actin: 1:4,000, 43 kDa; GAPDH: 1:1,000, 36 kDa) and quantified by densitometry with the Gel Image System (Bio-Rad).
Confocal Imaging. Confocal double immunofluorescence was used to investigate the coexistence of CRFR1 and AQP4 in cortex, mixed hippocampus neurons, and primary astrocyte culture. Before the reaction with primary antibodies, sections were fixed in 4% (wt/vol) buffered paraformaldehyde, incubated in 0.4% Triton X-100 in PBS for 30 min, and then blocked with 10% (vol/ vol) normal goat serum in PBS (pH 7.4) for 30 min at 37°C. Consecutive sections were incubated overnight at 4°C simultaneously with CRFR1 (Proteintech Group; 1:1,000) or AQP4 (Chemicon; 1:3,000) antibody and glial fibrillary acidic protein (GFAP; Abcam; 1:500) or DAPI (Invitrogen; 1 μg/mL). After incubation, sections were rinsed with PBS three times for 10 min and incubated with secondary antibodies for 1 h at 37°C. Immunofluorescence was analyzed by confocal microscopy (TE-2000; Nikon; Ultra-ViewERS; PerkinElmer) with Volocity 4D image analysis software. Negative controls for the immunofluorescence reaction were performed without primary antibody or with preadsorption immunizing peptide, and these sections yielded only background staining. CHO Cell Transgenic Method. Rat AQP4 plasmid (rAQP4) was generated by PCR with kpnI on the 5′ end and XhoI on the 3′ end and then inserted into the multiple cloning site of pcDNA3.1(+) plasmid (Invitrogen). The rat CRFR1α plasmid (P-R1R) was generated by PCR and constructed by inserting the BamHI and HindIII fragments spliced from pMD19-T (TaKaRa) into the multiple cloning site of pcDNA3.1(−) plasmid (Invitrogen). The CRFR1 cDNA clone was a gift from W. Vale (Salk Institute for Biological Studies, La Jolla, CA). CHO cells were cultured in 1640 medium supplemented with 10% (vol/vol) FBS at 37°C under 5% CO 2 . Cells were seeded on 24-well plates at 70-80% density 1 d before transfection. Transfection was carried out by using a modified liposome-mediated method according to the manufacturer's instructions. Briefly, plasmid DNA (0.67 μg for each of rAQP4 and P-R1R) and cotransfection of rAQP4/P-R1R was done at a ratio of 1:1 mixed with 2 μL of Lipofectamine 2000 (Invitrogen) in 50 μL of serum-free Opti-MEMI. After incubation for 20 min at room temperature, 100 μL of the mixture was layered onto the cells cultured in 1640 medium supplemented with 10% (vol/vol) FBS without antibody. Six hours later, the medium was replaced with serum-containing medium as described. At 24 h after transfection, water permeability was measured in CHO cells.
Drug Treatment. CRF (Phoenix Pharmaceuticals), CRFR1 antagonist, CP154,526 (provided by Pfizer), NBI (provided by Pfizer or NBI-27914, Sigma, N3911), NF-κB inhibitor, PDTC, PKG inhibitor, KT5823, and PKC inhibitor bisindolylmaleimide (Sigma), as well as LPS (Esherichia coli 055:B5, Sigma) were used for astrocyte cultures or CHO cell.
Osmotic Water Permeability Measurements. Osmotic water permeability was measured by using a published method (5) with modifications. Briefly, primary astrocytes or transfected cell lines were mounted in a closed perfusion chamber (Warner DH-35i; Live Cell System) on the stage of a TE-2000 inverted confocal laser scanning microscope (Nikon) in isotonic, 300 mOsm HBSS (HBSS buffer; Gibco). The cells were loaded with calcein by incubation with 20 μM calcein-AM (Molecular Probes, Invitrogen) for 5 min at 37°C. In some experiments, cells were preincubated with 100 nM CRFR1 antagonist CP154,526 (Pfizer) or 100 nM NBI (Pfizer) for 30 min at 37°C in the corresponding culture medium before calcein-AM loading. Only culture medium was added to the control cells. A series of images was recorded on a confocal laser scanning microscope by using a 40× objective every 2 s with excitation at 488 nm. The emitted fluorescence signal was collected at 515-525 nm with the focal plane set at 1/3 of the cell height from the bottom of the cell monolayer. After 10 s of recording, the perfusate was rapidly switched to hypoosmotic 200 mOsm HBSS with or without CRF. The recorded images were analyzed off-line to obtain the time course of calcein fluorescence in individual cells. Regions of interest (ROIs) were drawn along the inside of the cell membrane, and the mean intensity within the ROI was recorded every 2 s. The parts of the curves obtained immediately after the solution switch (6-10 s) were used for calculations. During these first seconds of exposure to the hypoosmotic solution, the rate of cell swelling is proportional to the permeability of the cellular membrane to water and is not influenced by mechanisms involved in regulatory volume decrease. The initial parts of the fluorescence curves were fitted with a single exponential function, and the time constant was used as a measure of the rate of cell swelling. ] i ) was measured according to a published method with modifications (6) . Briefly, cultured astrocytes on coverslips were incubated with 3 μM fura-3/AM for 45 min in physiological buffer in the dark at room temperature. Cells were then washed with buffer and stored in the dark for an additional 30 min to ensure fura-3/AM hydrolysis. Coverslips with loaded cells were transferred to a perfusion chamber and visualized under the microscope. Photon readings were taken by using a multifunctional microplate reader (Tecan; Infinite M200) at an excitation wavelength of 488 nm and emission at 526 nm. The [Ca 2+ ] i was computed from the equation [Ca
Immunoprecipitation. The lysate from 1 × 10 7 cells was used for one immunoprecipitation. The cells were washed twice with ice-cold PBS and lysed in radioimmunoprecipitation assay lysis buffer. The lysates were cleared by centrifugation at 16,000 × g for 15 min at 4°C. The supernatant was incubated with 10 μL of protein A/G agarose beads and incubated rocking for 1 h at 4°C. The bead-associated, nonspecifically absorbed proteins were removed by centrifugation for 15 s at 16,000 × g. The supernatant was then mixed with 20 μL of PPKAS, PPKCS (Cell Signaling; 1:50), and the mixture was incubated rocking for 1 h at 4°C. The samples were then transferred to protein A/G beads and incubated rocking overnight at 4°C. The beads were collected by centrifugation and washed three times with ice-cold PBS. After the final wash, the beads were resuspended in 50 μL of SDS/ PAGE sample buffer and boiled for 3 min. Then, AQP4 was separated by SDS/PAGE (10% gels) and ECL and analyzed as Western blot.
Quantitative Real-Time PCR. Total RNA was prepared by using TRIzol reagent (Life Technologies). RNA (2 μL) was reversetranscribed with oligo(dT) 12-18 primer by using the TransScript TM RT enzyme mix and then stored at 20°C.
The primer sequences were as follows:
5′-TAGCCACCCCTCAAGAATGAA-3′ (R);
CRFR1: 5′-CACTACCATGTTGCAGTCATC-3′ (F), 5′-CGAACATCCAGAAGAAGTTGG-3′ (R);
Endothelin-1 (ET-1): 5′-CACCTGGACATCATCTGG-3′ (F),
5′-CTGGCATCTGTTCCCTTG-3′ (R);
Bim: 5′-AGTCTCAGGAGGAACCTGAAGATCT-3′ (F),
5′-TCCGATCCTCCGCAGCT-3′ (R);
Bax: 5′-GGCTGGGAAGGCCTCCT-3′ (F),
5′-AGCCACAAAGATGGTCACTGTCT-3′ (R);
18S RNA: 5′-GTAACCCGTTGAACCCCATT-3′ (F),
5′-CCATCCAATCGGTAGTAGCG-3′(R);
GAPDH: 5′CCTCAAGATTGTCAGCAAT-3′ (F),
5′-CCATCCACAGTCTTCTGAGT-3′ (R).
Quantitative real-time PCR was carried out on a 7500 RealTime PCR System. A reaction solution consisting of 2 μL of cDNA product, 0.5 μL of PCR forward/reverse primer, 1 μL of ROX Reference DyeII, 8.5 μL of ddH 2 O, and 12.5 μL of SYBR Premix Ex TaqTM (TaKaRa) was used as the detection dye. Quantitative real-time PCR conditions were optimized in preliminary experiments to achieve a linear relationship between initial RNA concentration and PCR product. The temperature range to detect the melting temperature of the PCR product was set from 60°C to 95°C. The 18S or GAPDH was measured for each sample as an internal PCR control for sample loading and normalization. The specificity of the primers was verified by examining the melting curve as well as subsequent sequencing of the quantitative real-time PCR products.
H&E and TUNEL Staining. The protocol was carried out as suggested by the manufacturer (Chemicon). Briefly, rats were killed after hypoxia. Brains were harvested, frozen, and stored at −80°C. Brain sections (20 μm) were prepared and fixed in 4% (wt/vol) paraformaldehyde in PBS for 10 min at room temperature. Then sections were permeabilized with ethanol:acetic acid (2:1) for 5 min at −20°C. Terminal deoxynucleotidyltransferase enzyme was diluted in reaction buffer, and slices were incubated for 1 h at 37°C. Sections were then placed in stop/wash buffer and incubated for 10 min at room temperature. Antidigoxygenin conjugate was diluted in blocking solution, and slices were incubated for 30 min at room temperature. Exposure to light was avoided. Sections were washed four times in PBS (2 min each). Antifade containing 1 μg/mL DAPI was applied to sections, mounted under glass coverslip, and examined with confocal microscopy.
Assays for CRF, ET-1, and Corticosterone. Levels of CRF in the cortex were measured with a commercial enzyme immunoassay kit (Bachem) according to the manufacturer's protocol. ET-1 (Cayman Chemical) and plasma corticosterone (Cayman) were estimated with commercial ELISA kits for rats. The sensitivity of the assay was 0.40 ng/mL, and interassay and intraassay coefficients of variation were 6.5% and 4.5%, respectively. The antibody cross-reacted 100% with corticosterone and <0.5% with other steroids. Samples repeated from individual rats were analyzed within the same assay.
Brain Water Content. In another group, rats were rapidly decapitated, and brains were immediately removed and weighed after hypoxia exposure, dried at 120°C in a constant temperature oven, and reweighed until a constant dry weight was achieved. Water content of the brain was calculated as follows: brain water content = [(wet weight − dry weight)/wet weight] × 100%.
Statistical Analysis. All statistical analyses were performed by using SPSS software (Version 16.0). Data are presented as means ± SD. Statistical significance compared with control was determined with a two-tailed, unpaired Student's t test. Comparisons among multiple variables were determined with one-way ANOVA, followed by the Fisher least significance difference test. 
